DE69432665D1 - Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt - Google Patents

Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt

Info

Publication number
DE69432665D1
DE69432665D1 DE69432665T DE69432665T DE69432665D1 DE 69432665 D1 DE69432665 D1 DE 69432665D1 DE 69432665 T DE69432665 T DE 69432665T DE 69432665 T DE69432665 T DE 69432665T DE 69432665 D1 DE69432665 D1 DE 69432665D1
Authority
DE
Germany
Prior art keywords
saponin
clostridien
adjuvans
component vaccine
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69432665T
Other languages
English (en)
Other versions
DE69432665T3 (de
DE69432665T2 (de
Inventor
David S Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21899896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69432665(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69432665D1 publication Critical patent/DE69432665D1/de
Application granted granted Critical
Publication of DE69432665T2 publication Critical patent/DE69432665T2/de
Publication of DE69432665T3 publication Critical patent/DE69432665T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/842—Clostridium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69432665T 1993-03-29 1994-03-29 Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt Expired - Lifetime DE69432665T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3842893A 1993-03-29 1993-03-29
US38428 1993-03-29
PCT/US1994/003395 WO1994022476A1 (en) 1993-03-29 1994-03-29 Multicomponent clostridial vaccines using saponin adjuvants

Publications (3)

Publication Number Publication Date
DE69432665D1 true DE69432665D1 (de) 2003-06-18
DE69432665T2 DE69432665T2 (de) 2003-11-27
DE69432665T3 DE69432665T3 (de) 2007-12-06

Family

ID=21899896

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69432665T Expired - Lifetime DE69432665T3 (de) 1993-03-29 1994-03-29 Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt

Country Status (11)

Country Link
US (2) US6083512A (de)
EP (1) EP0692974B2 (de)
JP (1) JP4129544B2 (de)
AT (1) ATE240117T1 (de)
AU (1) AU689772B2 (de)
CA (1) CA2158651C (de)
DE (1) DE69432665T3 (de)
DK (1) DK0692974T4 (de)
ES (1) ES2199227T5 (de)
PT (1) PT692974E (de)
WO (1) WO1994022476A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
KR0184779B1 (ko) * 1995-04-13 1999-04-01 성재갑 퀼라야 사포나리아 몰리나로부터 분리정제된 사포닌 변이체, 이의 분리정제 방법 및 이를 함유하는 백신 제형
GB9620795D0 (en) * 1996-10-05 1996-11-20 Smithkline Beecham Plc Vaccines
AU1598297A (en) * 1996-02-02 1997-08-22 Boehringer Mannheim Gmbh Method of inactivation of ras subfamily proteins and agents therefor
FR2768747B1 (fr) * 1997-09-19 2000-12-01 Pasteur Institut Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
US6905712B2 (en) * 1999-12-08 2005-06-14 Statens Veterinarmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminum salt
DE10035156A1 (de) * 2000-07-19 2002-02-07 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Proteinkomplex als Vehikel für oral verfügbare Protein-Arzneimittel
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
US6974577B2 (en) * 2001-02-04 2005-12-13 Novartris Ag Inactivated bovine scours vaccines, processes and method of preventing bovine scours
US7220421B2 (en) * 2001-06-19 2007-05-22 The Regents Of The University Of California Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
MY149604A (en) 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
BR122019017005B1 (pt) 2011-04-22 2022-03-29 Wyeth Llc Composições que se relacionam a uma toxina de clostridium difficile mutante
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
CN106177935A (zh) * 2016-08-19 2016-12-07 齐鲁动物保健品有限公司 一种反刍动物梭菌病四联灭活疫苗及其制备方法
CN110244042B (zh) * 2019-07-24 2020-08-14 山东农业大学 羊腐败梭菌的间接elisa检测试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883425A (en) * 1973-12-10 1975-05-13 Wadley Res Inst & Blood Bank Detoxification of saponins
SU627612A1 (ru) * 1977-09-30 1980-02-05 Zemlyakova V P Препарат земл ковой в.п. против клюстридиозов животных и птиц
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
IT1198234B (it) * 1986-12-23 1988-12-21 Zambon Spa Processo stereoconvergente per la preparazione di acidi carbossilici otticamente attivi
US5583112A (en) * 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5043158A (en) * 1987-08-21 1991-08-27 Chembiomed, Ltd. Immunogenic compositions containing ordered carriers
NZ230747A (en) * 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
AU2297888A (en) * 1988-09-30 1990-04-05 Lovgren, Karin A complex comprising adjuvants and lipids
US5646247A (en) * 1989-04-05 1997-07-08 New York University Merozoite antigens localized at the apical end of the parasite
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
US5736139A (en) * 1989-10-31 1998-04-07 Ochidian Pharmaceuticals, Inc. Treatment of Clostridium difficile induced disease
US5270202A (en) * 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome

Also Published As

Publication number Publication date
EP0692974A1 (de) 1996-01-24
CA2158651C (en) 2009-09-01
DK0692974T3 (da) 2003-09-01
DE69432665T3 (de) 2007-12-06
DE69432665T2 (de) 2003-11-27
EP0692974B2 (de) 2007-05-30
DK0692974T4 (da) 2007-10-01
PT692974E (pt) 2003-09-30
ATE240117T1 (de) 2003-05-15
ES2199227T3 (es) 2004-02-16
ES2199227T5 (es) 2007-12-01
JP4129544B2 (ja) 2008-08-06
EP0692974B1 (de) 2003-05-14
AU6493994A (en) 1994-10-24
CA2158651A1 (en) 1994-10-13
US6083512A (en) 2000-07-04
WO1994022476A1 (en) 1994-10-13
US20010002256A1 (en) 2001-05-31
EP0692974A4 (de) 1999-04-07
AU689772B2 (en) 1998-04-09
JPH08510206A (ja) 1996-10-29

Similar Documents

Publication Publication Date Title
DE69432665T2 (de) Multikomponentenimpfstoff aus clostridien, der saponin als adjuvans benutzt
IT8709354A0 (it) Siringa per iniezioni,in specie endovenose,realizzata per poteressere usata una sola volta,senza possibilita' di riaspirazione.
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
FI941771A0 (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
BG105396A (en) Utilisation of dialkylfumarates
IL102848A0 (en) Polypeptides having growth hormone releasing activity,their use and pharmaceutical compositions containing them
PT99513A (pt) Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
UA26855C2 (uk) Фармацевтичhа композиція, яка регулює гематопоез
ES8708183A1 (es) Un procedimiento para la preparacion de una composicion liofilizada de lipidos.
DK0666739T3 (da) Intravenøs opløsning som formindsker protein- og vandtab fra kroppen
ZA91115B (en) Topical compositions
GB1216295A (en) New enzyme inhibitors and their preparation
ITRM920535A1 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
ES2037677T3 (es) Uso de un acido carboxilico en preparados farmaceuticos destinados a aplicacion topica.
Tamura A Comparative Study on the Family-Roles in Urban and Rural Areas (Part 1)
AU1248792A (en) Influenza virus vaccine composition having a synergistic effect and containing influenza virus core as an additive
陈樾荫 Trackmen head for Remsa'85
LIM FROM: CHERRY
TH14165EX (th) สารกันเสียสำหรับสารผสมตามสูตรที่ใช้ฉีด
TH14165A (th) สารกันเสียสำหรับสารผสมตามสูตรที่ใช้ฉีด
Mocsary Arpadhon: The largest rural Hungarian settlement in the United States
YOKOGI et al. On the Needed Labour of the Equipped Horticulture
Yuan-xi et al. Experimental Effects of the Cold-Resister for Increasing Cold-Resistance of Cotton Seedlings
Shimazu et al. The Scope of Reason Legislation in Hayek's Social Theory

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings